HPS Pharmacies wish to give notice that Novartis Pharmaceuticals is experiencing a supply interruption for Voltaren® Ophtha eye drops as follows:
Voltaren® Ophtha Eye Drops
Diclofenac sodium 1mg/mL
Normal supplies are expected to resume by end-March 2021. International brands of diclofenac eye drops may be accessed via the Special Access Scheme (SAS), if necessary. Please note that SAS alternatives are subject to a longer lead-time and different pricing as they must be sourced internationally.
Alternatively, other ocular non-steroidal anti-inflammatory drug (NSAID) preparations that are registered in Australia could be considered. These include ketorolac (Acular® ) and nepafenac (Ilevro®) eye drops.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Novartis Pharmaceuticals on 1800 671 203 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates